Syschem India Ltd. · BSE:SYSCHEM

Syschem India — Investor Presentation (August 2025)

19 slides from Syschem India's investor presentation, Aug 4, 2025

  1. Slide 1: Investor Presentation Quarter Jun-25

    INVESTOR PRESENTATION Quarter Jun-25

  2. Slide 2: Agenda

    AGENDA Company Overview 01 > Future Roadmap 05 Vision & Mission O02 C> Financial Snapshot 06 Why Invest In Syschem 03 e Geographical Presence 07 Problem & Solution 04 Be ESG Commitment 08

  3. Slide 3: Company Overview

    COMPANY OVERVIEW Syschem (India) Limited (SIL) is a listed company engaged in the manufacturing of Bulk Drugs/Intermediates and contract manufacturing. It is owned and operated by a highly committed group of techno commercial with extensive experience in the bulkdrug business. > The Company Is commi

  4. Slide 4: Vision & Mission

    ZS. SYSCHEM V7 INDIA N y fA? Nision & Mission Vision To become a leading and trusted global partner in the chemical and pharmaceutical industry by providing high-quality, innovative, and sustainable solutions. Syschem India Limited is committed to scientific excellence, regulatory compliance, and cr

  5. Slide 5: Why Invest in Syschem

    S SYSCHEM INDIA WHY INVEST IN SYSCHEM tan: AP OMI ORZORZO Over the past few years, Syschem Syschem’s manufacturing facility Syschem is committed to environmentally has demonstrated a steady increase in Kalka, Haryana is ISO-certified responsible manufacturing, employee in revenue, EBITDA, and profit

  6. Slide 6: Problem & Solution

    SYSCHEM INDIA PROBLEM & SOLUTION Problem Investor Pitch Deck STAFF COMPETITOR Syschem India faces challenges in attracting and The APIs and pharmaceutical industry is highly retaining highly skilled technical personnel due to competitive, with both domestic and international players increasing compe

  7. Slide 7: Future Roadmap

    S SYSCHEM INDIA FUTURE ROADMAP Strategic Expansion WHO-GMP Compliance Capacity Enhancement Construction of SIL's new The upcoming facility will adhere to This expansion’ will — significantly manufacturing unit for cloxacillin, WHO-GMP guidelines, ensuring the increase production capacity to cater to

  8. Slide 8: Financial Snapshot

    FINANCIAL SNAPSHOT REVENUE EBITDA (In Lakhs) PBT a (In Lakhs) (In Lakhs) a . . . a @ JUNE-24. @MAR-25 @ JUNE-25 a . . @ Jun-24 @Mar25 = @ Jun-25 @ JUN-24. @MAR25 @ JUN-25 . a a JUN-24 . . 82 . . a a . . . a a . . . . a a . . . a a . . . . a a . . . a a . . . . a a . . . a a be] JUNE-24 MAR-25 JUNE-2

  9. Slide 9: Financial Snapshot

    @ JUNE-24. @ Mar-25 FINANCIAL SNAPSHOT @ Jun-25 : @ Jun-24. @Mar25 @ Jun-25 :14000 "8.69, £12000 {1000c 8000 ote 1021%* 4000 : 2000 JUNE-24 Mar-25 Jun-25 ~~ Jun-24 Mar-25 ine The company experienced a modest dip in revenue in the June-25 quarter, attributed to weaker demand early inthe We are please

  10. Slide 10: Production

    PRODUCTION (In MT) 95% The company scaled up its production by 95% at the end of quarter March 2025, as @ Jun-24 @ Mar-25 @ Jun-25 compared to quarter ended Jun-24, 500 = demonstrating enhanced operational capacity and efficient resource utilization. 400 300 = 81% 200 In the end of quarter Jun-25 al

  11. Slide 11: Financial Abouts

    S SYSCHEM INDIA FINANCIAL ABOUTS QoQ INCREASE Improved Profit Margins The company reported a 24% qauarter- The company improved its EBITDA in the over-quarter increase in revenue for the quarter ending March 25, as well as in quarter ending June 25 compared to the subsequent quarter ending June quar

  12. Slide 12: Geographical Presence

    GY 313i GEOGRAPHICAL PRESENCE SUPPLY ZONE 24% Expanding operations and improving customer satisfaction are core goals for any thriving business. As we continue to grow, our focus remains on understanding and anticipating the needs of our customers, ensuring that we deliver unparalleled service and q

  13. Slide 13: Supply Zone

    45> SYSCHEM DOMESTIC PRESENCE SUPPLY ZONE The company has a diverse range of intermediate items in the pharmaceuticals industry that are created chemically. The company has established a foothold in India and the international market; its products have been exported to Latin America, Africa, Thailan

  14. Slide 14: ESG Commitment

    Employee health and safety as a top priority Community engagement and upliftment programs Adherence to national and Implementation of Inclusive growth and diversity international compliance sustainable manufacturing in the workplace standards practices Promoting a _ positive and Emphasis on ethical

  15. Slide 15: Safe Harbour Statement

    SAFE HARBOUR STATEMENT This Information Memorandum has been prepared by the Company based on information and data which the Company considers reliable. However, the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, re

  16. Slide 16: Safe Harbour Statement

    SAFE HARBOUR STATEMENT These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the wind power industry in India and worldwide, the Company's ability to successfully implement its st

  17. Slide 17: Our Management Team

    SYSCHEM INDIA V7. OUR MANAGEMENT TEAM Mr. Ranjan Jain Mr. Suninder Veer Singh Mr. Sanjeev Agrawal Ms. Shikha Kataria Managing Director Whole-Time Director Chief Financial Officer Company Secretary ; With: «over «25°. -years of He oversees Sales and With around 30 years of She plays a crucial role in

  18. Slide 18: Contact Us

    SYSCHEM INDIA CONTACT US Phone 0172-5070471 Email [email protected] Website syschem Location Head Office : 825, FF, NAC Manimajra , Chandigarh-161001 Factory at: Village Bargodam, Tehsil Kalka, Dist. Panchkula, Haryana-133302

  19. Slide 19: Thank You

    THANK YOU A Presentation by - S SYSCHEM INDIA

Syschem India — Investor Presentation (August 2025) on 6ix